Sosei Group Corporation's (Sosei Heptares') PIVLAZ (clazosentan sodium) 150 mg has received marketing approval from the Ministry of Food and Drug Safety (MFDS) in South Korea for the prevention...

View the Online Magazine

Launches

ACG showcases concept of next generation capsule filling machine – AF330 at CPHI and PMEC 2023

ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is set to unveil its next generation capsule filling...

ACG Engineering launches the SMARTCOATER X•ONE Series

ACG Engineering, a division of ACG, a leading supplier of integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is delighted to launch...

New development in the treatment of Alzheimer’s disease

A new development in the treatment of Alzheimer’s disease is now available that can help reduce symptoms and lessen the care burden for patients...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Outcome Management: The cure for pharma’s toughest trials – by Johannes Müller, co-founder and CEO of Workpath

The pharmaceutical sector is currently grappling with significant challenges that are impacting its operations and long-term viability.  Rising cost pressures due to inflation and...

Approvals

Manufacturiung

Finance

Research & Development
Latest

Absci and AstraZeneca to advance AI-driven oncology candidate

Absci Corporation is collaborating with AstraZeneca to deliver an AI-designed antibody against an oncology target. The collaboration combines Absci’s Integrated Drug Creation platform with AstraZeneca’s...

Cancer Research UK and Guardant Health collaborate to advance cancer research and clinical development activities

Cancer Research UK, one of the world’s largest charitable funders of cancer research, its innovation unit, Cancer Research Horizons, and Guardant Health, a precision...

AQEMIA forms $140m multi-year collaboration with Sanofi

AQEMIA, a pharmatech company leveraging AI and quantum-inspired physics to accelerate the discovery of small molecule drug candidates with higher probability of success in...

PRISM BioLab and Lilly enter into drug discovery collaboration on a protein-protein interaction target

PRISM BioLab, a discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, has entered into a License and Collaboration...

Arcturus Therapeutics receives Orphan Drug Designation from U.S. FDA for cystic fibrosis treatment

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for Arcturus Therapeutics' product candidate ARCT-032 to treat cystic fibrosis (CF). The FDA’s...

Appointments